Ascendiant Capital Markets Issues Positive Forecast for BioSig Technologies (NASDAQ:BSGM) Stock Price

BioSig Technologies (NASDAQ:BSGM) had its target price raised by Ascendiant Capital Markets from $2.50 to $2.75 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

BioSig Technologies Price Performance

Shares of NASDAQ:BSGM opened at $1.42 on Thursday. BioSig Technologies has a 12 month low of $0.20 and a 12 month high of $5.00. The company’s 50-day moving average price is $1.17 and its two-hundred day moving average price is $0.82.

BioSig Technologies Company Profile

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.